Metformin Extended-Release Compared to Metformin Immediate-Release in Patients with Type 2 Diabetes In a multicenter, randomized, double-blind, active-controlled, dose-ranging, parallel group trial extended-release metformin HCl 1500 mg once daily, extended-release metformin HCl 1500 mg per day in divided doses (500 mg in the morning and 1000 mg in the evening), and extended-release metformin HCl 2000 mg once daily were compared to immediate-release metformin HCl 1500 mg per day in divided doses (500 mg in the morning and 1000 mg in the evening)
Can you take peptides and GLP-1 medications together
Primary discontinuation was defined as the first date a patient was 60 days or more without any GLP-1 RA on hand, using fill dates and number of days of medication supplied to account for excess (carryover) medication from previous fills
The mechanisms of GLP-1 to improve NAFLD include improving lipid metabolism by regulating metabolism-related signaling pathways such as AMPK pathway [33] and JNK pathway [105]
Large cohort studies have shown no increased risk compared to other metabolic medications (Douros et al., 2025)